To challenge the federal Food and Drug Administration (FDA) final rule on laboratory developed tests (LDTs,) the Association for Molecular Pathology (AMP) filed a lawsuit on August 20, 2024, in the United States District Court for the Southern District of Texas. This is the second lab industry lawsuit challenging the LDT rule to be filed …
September 3, 2024, Intelligence: Late-Breaking Lab News Read More »
